Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

239 recalls · Class II, newest first

Class II · Moderate risk

Premier Value Tussin Cough DM

CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Ongoing Microbial contamination Seaway Pharma Inc. D-0215-2024
Class II · Moderate risk

Good Neighbor Pharmacy

MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.

Ongoing Microbial contamination Pharma Nobis LLC NDC 46122-741-38 D-0227-2024
Class II · Moderate risk

Sertraline Tablets

CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.

Ongoing cGMP deviation Legacy Pharmaceutical Packaging LLC NDC 68645-523-54 D-0205-2024
Class II · Moderate risk

Nystatin 150 Mu

Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Ongoing Labeling / mix-up Fagron, Inc NDC 51552-0041-1 D-0157-2024
Class II · Moderate risk

Nystatin 2 Bu

Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Ongoing Labeling / mix-up Fagron, Inc NDC 51552-0041-4 D-0156-2024
Class II · Moderate risk

Nystatin 500 Mu

Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Ongoing Labeling / mix-up Fagron, Inc NDC 51552-0041-3 D-0155-2024
Class II · Moderate risk

Nystatin 5bu

Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Ongoing Labeling / mix-up Fagron, Inc NDC 51552-0041-5 D-0154-2024
Class II · Moderate risk

Naproxen Tablets

Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen

Ongoing Labeling / mix-up Glenmark Pharmaceuticals Inc., USA NDC 68462-188-01 D-0124-2024
Class II · Moderate risk

Indomethacin 25mg Capsules

Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen

Ongoing Labeling / mix-up Glenmark Pharmaceuticals Inc., USA NDC 68462-406-01 D-0123-2024

Recalls by year